MX385381B - Cristal de compuesto que tiene actividad inhibidora de la cinasa de janus (jak). - Google Patents
Cristal de compuesto que tiene actividad inhibidora de la cinasa de janus (jak).Info
- Publication number
- MX385381B MX385381B MX2018010334A MX2018010334A MX385381B MX 385381 B MX385381 B MX 385381B MX 2018010334 A MX2018010334 A MX 2018010334A MX 2018010334 A MX2018010334 A MX 2018010334A MX 385381 B MX385381 B MX 385381B
- Authority
- MX
- Mexico
- Prior art keywords
- compound
- jak
- crystal
- inhibitory activity
- janus kinase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
- C07C309/30—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings of six-membered aromatic rings substituted by alkyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Un objeto de la presente invención es proporcionar un compuesto con una excelente actividad inhibidora de JAK1. El compuesto de la invención tiene actividad inhibidora de JAK1, y por lo tanto, efecto inmunosupresor, efecto antiinflamatorio, efecto antiproliferativo, etc., y es útil en el tratamiento de las enfermedades, por ejemplo, artritis reumatoide, enfermedad inflamatoria intestinal, psoriasis, vasculitis, asma bronquial, enfermedad pulmonar obstructiva crónica, sinusitis eosinofílica y pólipo nasal.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016039315 | 2016-03-01 | ||
| PCT/JP2017/007594 WO2017150477A1 (ja) | 2016-03-01 | 2017-02-28 | Ｊａｋ阻害作用を有する化合物の結晶 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2018010334A MX2018010334A (es) | 2018-11-09 |
| MX385381B true MX385381B (es) | 2025-03-18 |
Family
ID=59743962
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018010334A MX385381B (es) | 2016-03-01 | 2017-02-28 | Cristal de compuesto que tiene actividad inhibidora de la cinasa de janus (jak). |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US10822350B2 (es) |
| EP (1) | EP3424930B1 (es) |
| JP (1) | JP6791239B2 (es) |
| KR (1) | KR102653231B1 (es) |
| CN (1) | CN108699082B (es) |
| BR (1) | BR112018016523B1 (es) |
| CA (3) | CA3206830A1 (es) |
| CY (1) | CY1123607T1 (es) |
| DK (1) | DK3424930T3 (es) |
| ES (1) | ES2844978T3 (es) |
| HR (1) | HRP20210062T1 (es) |
| HU (1) | HUE051615T2 (es) |
| LT (1) | LT3424930T (es) |
| MX (1) | MX385381B (es) |
| PL (1) | PL3424930T3 (es) |
| PT (1) | PT3424930T (es) |
| RS (1) | RS61238B1 (es) |
| RU (1) | RU2705721C1 (es) |
| SI (1) | SI3424930T1 (es) |
| SM (1) | SMT202000717T1 (es) |
| TW (1) | TWI712604B (es) |
| WO (1) | WO2017150477A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI712604B (zh) * | 2016-03-01 | 2020-12-11 | 日商日本新藥股份有限公司 | 具jak抑制作用之化合物之結晶 |
| EP4627923A3 (en) * | 2020-09-14 | 2026-01-14 | EuroChem Antwerpen | N-heterocyclic compounds used as nitrification inhibitor |
| WO2025216268A1 (ja) * | 2024-04-09 | 2025-10-16 | 国立研究開発法人国立循環器病研究センター | 重症肺高血圧症又は膠原病の予防又は治療薬 |
| JP7742516B1 (ja) * | 2025-07-31 | 2025-09-19 | 日本新薬株式会社 | 好酸球性多発血管炎性肉芽腫症の処置剤 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3600390A1 (de) | 1986-01-09 | 1987-07-16 | Hoechst Ag | Diarylalkyl-substituierte alkylamine, verfahren zu ihrer herstellung, ihre verwendung sowie sie enthaltende arzneimittel |
| DK1704145T3 (da) | 2004-01-12 | 2012-09-24 | Ym Biosciences Australia Pty | Selektive kinaseinhibitorer |
| EP2532667A1 (en) * | 2005-09-30 | 2012-12-12 | Vertex Pharmaceuticals Incorporated | Deazapurines useful as inhibitors of janus kinases |
| AR060316A1 (es) | 2006-01-17 | 2008-06-11 | Vertex Pharma | Azaindoles de utilidad como inhibidores de janus quinasas |
| PL2288610T3 (pl) | 2008-03-11 | 2017-12-29 | Incyte Holdings Corporation | Azetydynowe i cyklobutanowe pochodne jako inhibitory jak |
| JO3041B1 (ar) | 2008-07-25 | 2016-09-05 | Galapagos Nv | مركبات جديدة مفيدة لمعالجة الأمراض التنكسية والالتهابية |
| ES2422263T3 (es) * | 2008-12-19 | 2013-09-10 | Nerviano Medical Sciences Srl | Pirazoles bicíclicos como inhibidores de la proteinquinasa |
| TWI462920B (zh) * | 2009-06-26 | 2014-12-01 | 葛萊伯格有限公司 | 用於治療退化性及發炎疾病之新穎化合物 |
| WO2011075334A1 (en) | 2009-12-18 | 2011-06-23 | Pfizer Inc. | Pyrrolo[2,3-d]pyrimidine compounds |
| EP2338888A1 (en) | 2009-12-24 | 2011-06-29 | Almirall, S.A. | Imidazopyridine derivatives as JAK inhibitors |
| JP2011136925A (ja) | 2009-12-28 | 2011-07-14 | Dainippon Sumitomo Pharma Co Ltd | 含窒素二環性化合物 |
| US8461328B2 (en) | 2010-01-12 | 2013-06-11 | Genentech, Inc. | Tricyclic heterocyclic compounds, compositions and methods of use thereof |
| UY33213A (es) | 2010-02-18 | 2011-09-30 | Almirall Sa | Derivados de pirazol como inhibidores de jak |
| WO2012022045A1 (en) | 2010-08-20 | 2012-02-23 | Hutchison Medipharma Limited | Pyrrolopyrimidine compounds and uses thereof |
| WO2012037132A1 (en) | 2010-09-14 | 2012-03-22 | Exelixis, Inc. | Phtalazine derivatives as jak1 inhibitors |
| US8937077B2 (en) | 2010-10-22 | 2015-01-20 | Merck Sharp & Dohme Corp. | Bicyclic diamines as janus kinase inhibitors |
| WO2012085176A1 (en) | 2010-12-23 | 2012-06-28 | F. Hoffmann-La Roche Ag | Tricyclic pyrazinone compounds, compositions and methods of use thereof as janus kinase inhibitors |
| WO2013025628A1 (en) * | 2011-08-15 | 2013-02-21 | Ligand Pharmaceuticals Incorporated | Janus kinase inhibitor compounds and methods |
| TWI679205B (zh) | 2014-09-02 | 2019-12-11 | 日商日本新藥股份有限公司 | 吡唑并噻唑化合物及醫藥 |
| TWI712604B (zh) * | 2016-03-01 | 2020-12-11 | 日商日本新藥股份有限公司 | 具jak抑制作用之化合物之結晶 |
-
2017
- 2017-02-08 TW TW106104074A patent/TWI712604B/zh active
- 2017-02-28 LT LTEP17759943.8T patent/LT3424930T/lt unknown
- 2017-02-28 HU HUE17759943A patent/HUE051615T2/hu unknown
- 2017-02-28 PT PT177599438T patent/PT3424930T/pt unknown
- 2017-02-28 JP JP2018503309A patent/JP6791239B2/ja active Active
- 2017-02-28 CA CA3206830A patent/CA3206830A1/en active Pending
- 2017-02-28 WO PCT/JP2017/007594 patent/WO2017150477A1/ja not_active Ceased
- 2017-02-28 EP EP17759943.8A patent/EP3424930B1/en active Active
- 2017-02-28 ES ES17759943T patent/ES2844978T3/es active Active
- 2017-02-28 US US16/077,889 patent/US10822350B2/en active Active
- 2017-02-28 CA CA3015464A patent/CA3015464C/en active Active
- 2017-02-28 KR KR1020187027122A patent/KR102653231B1/ko active Active
- 2017-02-28 RU RU2018134041A patent/RU2705721C1/ru active
- 2017-02-28 MX MX2018010334A patent/MX385381B/es unknown
- 2017-02-28 BR BR112018016523-9A patent/BR112018016523B1/pt active IP Right Grant
- 2017-02-28 SM SM20200717T patent/SMT202000717T1/it unknown
- 2017-02-28 HR HRP20210062TT patent/HRP20210062T1/hr unknown
- 2017-02-28 SI SI201730521T patent/SI3424930T1/sl unknown
- 2017-02-28 CA CA3264321A patent/CA3264321A1/en active Pending
- 2017-02-28 PL PL17759943T patent/PL3424930T3/pl unknown
- 2017-02-28 RS RS20201509A patent/RS61238B1/sr unknown
- 2017-02-28 DK DK17759943.8T patent/DK3424930T3/da active
- 2017-02-28 CN CN201780014551.5A patent/CN108699082B/zh active Active
-
2020
- 2020-09-29 US US17/035,947 patent/US11377453B2/en active Active
- 2020-12-02 CY CY20201101142T patent/CY1123607T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201591462A1 (ru) | Антитела против il-17a и их применение для лечения аутоиммунных и воспалительных нарушений | |
| CL2015002301A1 (es) | Acido 2-aza-biciclo[2.2.1]heptano-3-carboxílico (bencil-ciano-metil)-amidas sustituidas inhibidores de catepsina c. | |
| EA201590721A1 (ru) | Фармацевтические композиции, содержащие ингибитор pde4 и ингибитор pi3-дельта или двойной ингибитор pi3-дельта-гамма киназы | |
| EA201400729A1 (ru) | ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ СОДЕРЖАТ ГЛИТАЗОНЫ И Nrf2 АКТИВАТОРЫ | |
| PH12016502099A1 (en) | 5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds which are jak inhibitors | |
| MX385381B (es) | Cristal de compuesto que tiene actividad inhibidora de la cinasa de janus (jak). | |
| HK1249104A1 (zh) | 作为HDAC8抑制剂的α-肉桂酰胺化合物和组合物 | |
| EA201890185A1 (ru) | Способы лечения опосредованных гепсидином нарушений | |
| JO3458B1 (ar) | 2- أمينو-6- (دايفلوروميثيل) – 5، 5- ديفلورو-6-فينيل-3،4، 5، 6-تيتراهيدروبيريدين كمثبطات bace1 | |
| GEP20186885B (en) | Novel compounds | |
| UY35654A (es) | Dihidroquinoxalinonas y dihidropiridopirazinonas modificadas como inhibidores de la proteína bet | |
| CO2017002982A2 (es) | Compuesto de pirazolotiazol y medicamento que comprende el mismo | |
| UY35370A (es) | Moduladores benzoimidazol-2-il pirimidina del receptor de histamina h4 | |
| EA201790072A1 (ru) | Производные 2-арил-4-гидрокси-1,3-тиазола для применения в качестве ингибиторов trpm8 в лечении невралгии, болей, хронической обструктивной болезни лёгких и астмы | |
| EA201391155A1 (ru) | Ингибитор катепсина с | |
| BR112017004163A2 (pt) | método de tratamento e composições com um inibidor de quinase pi3k delta e gamma duplo e um corticostoide | |
| MX2018005259A (es) | Inhibidores de gelatinasa y uso de los mismos. | |
| MX2021015553A (es) | Inhibidores de arginasa novedosos. | |
| IL310039A (en) | Large scale adeno-associated virus production systems | |
| MX370251B (es) | Derivados de difeniloxialquilamina y derivados de ariloxialquilamina, composicion farmaceutica, uso de dicha composicion farmaceutica para tratar, prevenir o inhibir enfermedades inflamatorias pulmonares cronicas y metodo para tratar o prevenir dichas enfermedades. | |
| EP3495531C0 (en) | ALUMINUM ROLLING PROCESS FOR FINE GRAIN APPLICATIONS | |
| MY192305A (en) | Bipyrazole derivatives as jak inhibitors | |
| UA113645C2 (xx) | ТРИАЗОЛОНИ ЯК ІНГІБІТОРИ mPGES-1 |